Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An In Silico and In Vitro Approach

Purpose: Sorafenib is the sole FDA approved drug conventionally used for the treatment of advanced hepatocellular carcinoma (HCC). Despite of the beneficial use of sorafenib in the treatment of HCC, multidrug resistance still remains a challenge. HCC is inherently known as chemotherapy resistant tum...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Adv Pharm Bull
Main Authors: Nair, Bhagyalakshmi, Anto, Ruby John, M, Sabitha, Nath, Lekshmi R.
Format: Artigo
Jezik:Inglês
Izdano: Tabriz University of Medical Sciences 2020
Teme:
Short Communication
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7335979/
https://ncbi.nlm.nih.gov/pubmed/32665908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.34172/apb.2020.058
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki